Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis

Alyssa M. Flores(Stanford University), Niloufar Hosseini-Nassab(Stanford University), Kai-Uwe Jarr(Stanford University), Jianqin Ye(Stanford University), Xingjun Zhu(Stanford University), Robert Wirka(Stanford University), Ai Leen Koh(Stanford University), Pavlos Tsantilas(Stanford University), Ying Wang(Stanford University), Vivek Nanda(Stanford University), Yoko Kojima(Stanford University), Yitian Zeng(Stanford University), Mozhgan Lotfi(Stanford University), Robert Sinclair(Stanford University), Irving L. Weissman(California Institute for Regenerative Medicine), Erik Ingelsson(Cardiovascular Institute of the South), Bryan Ronain Smith(Quantitative BioSciences), Nicholas J. Leeper(Cardiovascular Institute of the South)
Nature Nanotechnology
January 27, 2020
Cited by 280Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis